[HTML][HTML] Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project

RL Santi, F Martinez, A Baranchuk… - European Cardiology …, 2021 - ncbi.nlm.nih.gov
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …

[PDF][PDF] Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project

RL Santi, F Martinez, A Baranchuk, AS Liprandi… - 2021 - assets.radcliffecardiology.com
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …

Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project

RL Santi, F Martinez, A Baranchuk… - European …, 2021 - pubmed.ncbi.nlm.nih.gov
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …

[PDF][PDF] Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project

RL Santi, F Martinez, A Baranchuk, AS Liprandi… - 2021 - core.ac.uk
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …

Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project.

RL Santi, F Martinez, A Baranchuk, AS Liprandi… - European …, 2021 - europepmc.org
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …

[PDF][PDF] Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project

RL Santi, F Martinez, A Baranchuk, AS Liprandi… - 2021 - researchgate.net
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …

Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project.

RL Santi, F Martinez, A Baranchuk, AS Liprandi… - Eur …, 2021 - openaccess.sgul.ac.uk
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …

[PDF][PDF] Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project

RL Santi, F Martinez, A Baranchuk, AS Liprandi… - 2021 - openaccess.sgul.ac.uk
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …

[PDF][PDF] Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project

RL Santi, F Martinez, A Baranchuk, AS Liprandi… - 2021 - assets.radcliffecardiology.com
Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year,
scientific institutions publish cardiovascular prevention guidelines with updated goals and …